Abstract
Background
While self-monitoring of blood glucose (SMBG) is recommended as a core aspect of management for people with type 1 diabetes and those with type 2 diabetes using insulin, its use by people with noninsulin treated type 2 diabetes remains contentious and continues to provoke ongoing debate. [1] [2] [3] While systematic reviews and meta-analyses have challenged the overall clinical benefit of SMBG in this population, [4] [5] [6] [7] there is considerable heterogeneity among published trials. These differ in how they have operationalised and implemented SMBG as well as in design, study population and approaches to recruitment.
Those who oppose SMBG in individuals with non-insulin treated type 2 diabetes argue that that there is little they or their GPs can do with the results, rendering the technology a waste of time and resources. 8 Others argue that, like any tool, SMBG is used most appropriately by those trained to use it and motivated and able to act upon the results. Thus, based on the argument that such training would lead to better self-management of the condition and a reduced rate of complications, SMBG may save money in the long term. 9 Self-monitoring of urine glucose is just as contentious. While urine monitoring is considerably less expensive than SMBG and easier to perform, it is also regarded as less hygienic and less informative. 10 Urine monitoring cannot identify hypoglycaemia, (a significant risk in those taking sulphonylureas) since urine strips only indicate when glucose rises above the renal threshold of around 11mmol/l. Urine monitoring is also unreliable in those taking SGLT2 inhibitors since they promote increased urinary loss of glucose by lowering the renal threshold. Given the prominence of the debate about the role of SMBG and urine monitoring in adults with non-insulintreated T2DM (for example 8, 9 ), primary care staff may have strong opinions about one or both technologies and/or may be wary about what to recommend regarding self-monitoring.
The DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) SelfMonitoring Trial -a multi-site cluster randomised controlled trial -has contributed to this debate by assessing the equivalence of SMBG and urine glucose monitoring in adults with newly diagnosed type 2 diabetes, while controlling for provision of self-management education. 11, 12 The trial reported a significant reduction of the primary outcome (glycated haemoglobin; HbA1c), in both groups over 18 months of follow-up, but no significant between-group difference. 12 Other biomedical and psychosocial outcomes also improved over 18 months with no differences between the groups. Of note, participants in the blood monitoring group were more likely to report continued use of their allocated method at 18 months than those randomised to urine monitoring, with 18% of the urine monitoring group switching to blood monitoring after 18 months. In contrast, very few participants swapped from blood to urine monitoring. 12 While there was a decline over time in the number of participants continuing to use blood monitoring (86% at 6 months, 85% at 12 months and 79% at 18 months), there was a steeper decline in the urine monitoring group (74%, 69% and 59% respectively). 12 Sensitivity analysis revealed greater satisfaction with treatment and a more threatening view of diabetes in the blood monitoring group (although the latter was only present at six months).
12
Previous qualitative research exploring the experiences of people with type 2 diabetes provides insight into the acceptability of the two monitoring methods. Negative views about the usability of urine monitoring have been reported due to confusion about the readings and a perception that it is unhygienic. 10 SMBG has been reported as more useful -providing individuals with direct evidence of the effects of their behaviour on glucose levels (through understanding of the relationship between blood glucose and symptoms), and providing positive reassurance when achieving optimal blood glucose levels. 13, 14 However, distress and confusion at unexpected and unexplained blood glucose readings, leading in some cases to a sense of failure and self-blame, were also reported. [13] [14] [15] A progressive decline in monitoring was influenced by these experiences but also by primary healthcare professionals, who either disapproved of the monitoring method or showed little interest in the results. 15 However, a limitation of previous qualitative studies is that they have generally not acknowledged how participants were trained to use the different methods of monitoring or how these were incorporated into the overall approach to self management. 10 We used a mixed methods approach in the DESMOND Self-Monitoring Trial, to explore the acceptability of the two monitoring methods (blood and urine) in people with newly diagnosed type 2 diabetes, who had experienced equivalent education in self-management and training in monitoring, and had been allocated randomly to one of the two methods. 11 Our aim was to provide insight into the quantitative results of the DESMOND Self-Monitoring Trial, 12 identifying issues contributing to the differences found between arms in the continued use of, and satisfaction with, the two methods, and the level of threat perceived from diabetes.
Methods
Ethical approval was granted (as part of the DESMOND Self-Monitoring Trial) by Cambridgeshire (UK) Research Ethics Committee (07/H0304/129). Local research governance approval was received from participating five Primary Care Trusts -public authorities in England which, at the time of this study, had responsibility for funding NHS services in a defined geographical area.
Participants
A sample of participants in the DESMOND Self-Monitoring Trial 11 was invited to participate in a semistructured individual interview approximately 12 months after attending the education sessions (i.e. 12 months into the trial). Purposive sampling guided recruitment to maximise diversity in age, gender, location, diabetes-specific well-being and treatment satisfaction (the latter two from participants' scores on returned questionnaires for the main trial). 11, 16, 17 Individuals were sent an invitation letter with an opt-in reply slip accompanied by a participant information leaflet. The interviewer telephoned each participant who returned a reply slip to check their willingness and arrange an interview.
Data collection
Interviews were conducted in the interviewees' homes. Written informed consent was taken prior to the interview. A semi-structured topic guide was used which covered: awareness, views, and experience of self-monitoring and monitoring method(s) -before, during and after the education session; perceptions of confidence in managing glucose levels; views about the education sessions;
and views about the trial. Interviews were audio-recorded, transcribed in full and anonymised.
Interview transcripts were reviewed (by HE) during the course of data collection in order to determine the point at which saturation had been reached; after completing 18 interviews, it was considered that new themes were no longer emerging and areas of interest had been adequately explored.
Analysis
Analysis was informed by the constant comparative approach. 18 Transcripts of the initial nine Quotations from interviewees are labelled by geographical area (A-E) and qualitative study ID number
(1-18). Gender; age group (<50, 50-70, >70 years) and monitoring method are also noted to provide participant characteristics without identification.
Results
Eighteen adults with newly diagnosed type 2 diabetes who were participating in the DESMOND SelfMonitoring Trial took part in the interview study. Ten had been allocated to SMBG and eight to urine self-monitoring; seven were women, and the age range was 29-80 years. All interviewees had attended DESMOND structured group-based education, with equivalent training in monitoring for their allocated method. Interviewees were geographically located in five Primary Care Trusts.
We present the qualitative data under key themes that relate closely to the findings reported in the DESMOND Self-Monitoring Trial results paper. 12 
Use of allocated monitoring method and treatment satisfaction
The qualitative data support the trial's finding of higher treatment satisfaction and continued use of Associated with this learning, most interviewees in the SMBG group mentioned an improved sense of personal control and independence. The opportunity and ability to self-monitor was reported as a way to avoid unnecessary visits to primary healthcare practitioners, thus reported as benefiting both individuals and their practitioners (Box 1, E2). Furthermore, two interviewees talked about how SMBG facilitated their self-management by serving as a disciplinary device, acting as a visible reminder when blood glucose levels were higher than ideal (Box 1, D5).
Interviewees' accounts provide two predominant explanations for the gradual decline in frequency of SMBG reported in the trial findings. 11 Most of this group reported reducing self-monitoring to once or twice a week, with three monitoring daily. The most common explanation for this decline was that SMBG was needed less frequently, having established a pattern of how to manage blood glucose following a period of monitoring and learning (Box 1, A1). A second explanation was due to perceived lack of support from their primary healthcare practitioners: lack of encouragement, lack of help interpreting results or disapproval about the method due to its purported futility or the cost of prescribing testing strips (Box 1, E1). Lack of support meant not acquiring information needed to interpret and act on their monitoring results, and for others it removed the incentive or "sense of purpose" (Box 1, D1). Only one participant in the qualitative study sample had swapped from SMBG to urine monitoring.
In the urine monitoring group, half of the interviewees were still regularly using their allocated method at 12 months, although all but one was monitoring less frequently than previously. This half had not questioned its accuracy and were content with its ease and convenience (Box 2, D2). The other half recalled finding it useful initially but, over time, had altered their views. After approximately one year into the trial, this sub-group considered urine monitoring to be inaccurate and of little value, reported only ever receiving "normal" results, and typically referred to it as a "waste of time" (Box 2, B1). These all mentioned how their healthcare practitioner had agreed, referring to it as inaccurate (Box 2, A2), not useful or expensive. This had triggered three interviewees to switch to SMBG (Box 2, A3); at least one case as a result of their practitioner's advice (Box 2, A2).
Perceived threat from diabetes and diabetes-specific concerns
Regarding the between-group difference in threat perception reported in the trial, 11 when asked directly about severity of diabetes, all interviewees in the urine monitoring group, and most in the SMBG group described their diabetes as "not too bad" or "borderline" (Box 3 D6). Interviewees across the two groups typically explained this perception by referring to a lack of symptoms, and due to currently controlling (or aiming to control) their diabetes using diet rather than medication. The urine monitoring group interviewees further explained this by referring to their consistently "normal" urine readings as evidence of this (Box 3, D4). This had led some in this group to conclude that their diabetes was well managed, and three interviewees to question their diagnosis altogether (Box 3, D4), supporting previous research. 10 There was little evidence of diabetes-related worry in these interviewees' accounts, which aligns with the trial's report of a less threatening view of diabetes in the urine monitoring group. 12 In contrast, it was clear that SMBG provided visible evidence of having diabetes and of the effect of self-care behaviours -such as differing quantity/type of foods or levels of physical activity -on blood glucose levels. While a couple of interviewees in the SMBG group reported worry following a high blood glucose reading, most reported working out its cause (usually a case of having "slipped" from an otherwise healthy diet) and acknowledged how high readings served as a reminder of both the importance of maintaining optimal self-care and of the seriousness of the condition (Box 3, C1). More instances of diabetes-related concerns emerged in the interviews with the SMBG group, than those allocated to urine monitoring. For example, a few mentioned feeling low or that their diabetes was controlling them (Box 3, C2). Two interviewees in the SMBG group, who had reported diabetes to be more serious than others did, described how not having achieved as great a reduction in their blood glucose as they had wanted had led to lowering of their mood (Box 3, D1).
Discussion
The DESMOND Self-Monitoring Trial reported that people with newly diagnosed type 2 diabetes who attended structured education had comparable improvements over 18 months in glycaemic control regardless of being randomised to SMBG or urine monitoring. However, between-group differences were apparent in continued use of monitoring method, and perceived threat from diabetes and, in the per protocol analysis, in treatment satisfaction. 12 By exploring the experiences of participants in both trial arms, the current qualitative study contributes to our understanding of these differences. reported not perceiving their diabetes as serious due to managing it with diet only, lacking symptoms, and -for those urine monitoring -viewing consistently 'normal' glucose readings (i.e. below the renal threshold). SMBG provided more visible evidence of diabetes via the effect of self-care behaviours on blood glucose, and more diabetes-related concerns emerged in this group as a result.
Explaining levels of engagement in self-monitoring
The trial reported that participants randomised to SMBG were significantly more likely to be continuing to use their allocated method at 6, 12 and 18 months, compared with the urine monitoring group. 12 Our qualitative findings support and inform the trial results: interviewees reported SMBG as helpful for learning how to interpret symptoms and the effects of self-care behaviours (quantity/type of foods eaten and physical activity) on their blood glucose; the gradual decline in blood monitoring over time reflected a view of a reduced need for such frequent monitoring after this period of learning. This suggests that people with newly diagnosed type 2 diabetes had learned principles for self-care based on their blood glucose readings and then applied these in routine daily life. It might be useful to anticipate this decline by modifying self management education and encouraging the use of selfmonitoring periodically to check these principles were still sound or to experiment with new self-care behaviours. In contrast, the steep decline in urine monitoring was explained as resulting from dissatisfaction and perceived 'uselessness' by many individuals. Those who switched to blood monitoring reported being keen to engage in self-management and to have tools to facilitate this.
The trial reported a temporarily more threatening view of diabetes in the blood monitoring group. The qualitative findings indicate that SMBG provided a more visible reminder, both of having diabetes and the effect of activities on blood glucose, than urine monitoring. Such visibility, in combination with the education and tools to enable action, appeared to raise the threat enough to promote better awareness, yet was not sufficiently overwhelming to lead to hopelessness or undue anxiety. In contrast, the lack of visibility of diabetes from urine monitoring led some interviewees to question their diagnosis. However, with the trial reporting no difference between the arms on HbA1c reduction, this increased awareness does not seem to have translated to more effective blood glucose management, at least in those recently diagnosed.
The potential influence of healthcare professionals on self-monitoring
Professionals at participating primary care practices received training about the aims and conduct of the trial and were asked to provide impartial advice about monitoring methods to their participating patients, 11 but, despite this, some of interviewees reported discouragement from professionals (consistent with previous research 15 ). Indeed, lack of professional support and/or feedback about selfmonitoring results or lack of willingness to prescribe monitoring strips emerged as reasons for stopping self-monitoring. Some of this discouragement may relate to concerns about the associated prescription costs 19 or, since these were refunded in the DESMOND Self-Monitoring Trial, it may reflect the wider debate about clinical and cost-effectiveness of such self-monitoring in non-insulin treated type 2 diabetes. 8, 9 Furthermore, while considerable efforts were made to ensure the impartiality of educators throughout the trial, 12,20 training for primary care staff was neither extensive nor continuous due to the multi-site design of the study and large number of practices involved. Thus, staff may have forgotten their instructions that their attitudes might influence the outcomes of the trial.
Primary healthcare professionals may require additional training to ensure that they and their patients understand the value of 'structured' blood glucose monitoring, and are trained to interpret the results; which has been demonstrated to be both feasible and effective in a recent trial. 21 Furthermore, additional patient education on incorporating monitoring into self-management, perhaps via a followup session focused on interpreting results -after a sufficient period of time of monitoring and experimenting with it -might be useful.
Strengths and limitations
Our findings support those of previous qualitative research conducted in non-trial contexts. 10 teams are under pressure to reduce costs. This may lead them to discourage patients from testing their blood. These differences might limit the generalizability of these findings outside the UK.
However, many of the findings of this study (for example the powerful influence of the attitudes of healthcare professionals) are relevant to care in other countries. Thus, awareness of patient acceptability of self-monitoring and the influence of professional views are relevant messages for all professionals involved in diabetes care.
Conclusions
The findings from this qualitative study support the conclusion of the trial -that while there may be no differences in biomedical improvement between people with newly diagnosed T2DM allocated to selfmonitoring blood or urine glucose as part of a structured education programme, the reported differences in acceptability suggest that those who are actively using SMBG, and do not find urine monitoring useful, could be encouraged to continue by their primary care professionals. 12 However, it would also appear to be reasonable for professionals to support those for whom urine monitoring is 
